Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of Bone”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02269280
What this trial is testing

Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 185
Large-scale testing (Phase 3)Study completedNCT00774280
What this trial is testing

Busulfan Plus Cyclophosphamide vs Fludarabine as a Conditioning Regimen

Who this might be right for
LeukemiaMyelodysplastic Syndrome
Cooperative Study Group A for Hematology 130
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07160283
What this trial is testing

The Efficacy and Safety of Trilaciclib in Bone Marrow Protection Before Chemotherapy for Advanced Bile Duct Cancer and Pancreatic Cancer

Who this might be right for
Biliary Tract NeoplasmsPancreatic Neoplasms
The Second Affiliated Hospital of Shandong First Medical University 96
Not applicableStudy completedNCT01160705
What this trial is testing

Biomarkers of Response to Taxotere in HRPC. ICORG 08-08, V2

Who this might be right for
Metastatic CancerProstate Cancer
Cancer Trials Ireland 73
Testing effectiveness (Phase 2)Study completedNCT01091103
What this trial is testing

Determine Effect of Enzalutamide (MDV3100) on the Androgen Signaling Pathway in Correlation With the Anti-tumor Effects of Enzalutamide

Who this might be right for
Metastatic Progressive Castration-resistant Prostate Cancer
Pfizer 60
Not applicableUnknownNCT01224873
What this trial is testing

Diagnosis of Bone Metastases in Breast Cancer: Bone Scintigraphy, Fluoride-PET and FDG-PET

Who this might be right for
Breast Cancer
Rigshospitalet, Denmark 110
Post-approval studies (Phase 4)Study completedNCT01907880
What this trial is testing

The ODYSSEY TRIAL Phase IV Trial Evaluating the Palliative Benefit of Pamidronate or Zoledronic Acid in Breast Cancer

Who this might be right for
Breast Cancer
Ottawa Hospital Research Institute 74
Early research (Phase 1)Study completedNCT00005796
What this trial is testing

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Who this might be right for
Bone Marrow SuppressionBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/Organ
Indiana University 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT04316546
What this trial is testing

MK-7075 (Miransertib) in Proteus Syndrome

Who this might be right for
Proteus Syndrome
National Human Genome Research Institute (NHGRI) 38
Not applicableStudy completedNCT00436696
What this trial is testing

Genetic Analysis Using Blood or Bone Marrow From Participants With Neuroblastoma or Noncancerous Conditions

Who this might be right for
Localized Resectable NeuroblastomaLocalized Unresectable NeuroblastomaRecurrent Neuroblastoma+2 more
Children's Oncology Group 9,350
Testing effectiveness (Phase 2)Study completedNCT01930162
What this trial is testing

Safety and Tolerability of HSC835 in Patients With Hematological Malignancies Undergoing Single Umbilical Cord Blood Transplant

Who this might be right for
Single Umbilical Cord Blood TransplantationNon-myeloablative ConditioningAcute Lymphocytic Leukemia+4 more
Novartis Pharmaceuticals 9
Early research (Phase 1)Study completedNCT00415779
What this trial is testing

ZANTE: Zometa and Taxotere in Hormone Refractory Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
National Cancer Institute, Naples 36
Testing effectiveness (Phase 2)Study completedNCT00096096
What this trial is testing

Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00005962
What this trial is testing

Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia

Who this might be right for
Leukemia
Eastern Cooperative Oncology Group
Not applicableUnknownNCT05609227
What this trial is testing

Effect of Mobile Application on Supportive Care Needs and Quality of Life Patients Undergoing Hematopoietic Stem Cell Transplantation

Who this might be right for
Hematologic MalignancyPatient Education
Baskent University 36
Testing effectiveness (Phase 2)Ended earlyNCT00038142
What this trial is testing

Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients

Who this might be right for
Ewing's Sarcoma
M.D. Anderson Cancer Center 46
Early research (Phase 1)Looking for participantsNCT07297979
What this trial is testing

Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)

Who this might be right for
Ewing Sarcoma
Amgen 50
Testing effectiveness (Phase 2)Study completedNCT00489203
What this trial is testing

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Hematopoietic/Lymphoid CancerAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+133 more
Fred Hutchinson Cancer Center 140
Testing effectiveness (Phase 2)WithdrawnNCT05612633
What this trial is testing

Zelavespib (PU-H71) in Subjects With AP-MPN or BP-MPN

Who this might be right for
Accelerated Phase MPNBlast Phase MPN
Samus Therapeutics, Inc.
Next Page